Clinical Trial Update: Trial of Bortezomib, Cytarabine, and Dexamethasone in Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating a combination of bortezomib, cytarabine, and dexamethasone in mantle cell lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Bortezomib (bortezomib)
• CYTARABINE (CYTARABINE)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Mantle Cell Lymphoma | Phase 2 | Status: COMPLETED